JANE BUCHAN - 20 Jun 2025 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
Director
Signature
/s/ Ilya Rachman as Attorney-In-Fact for Jane Buchan
Issuer symbol
IMMX
Transactions as of
20 Jun 2025
Net transactions value
$0
Form type
4
Filing time
23 Jun 2025, 16:57:32 UTC
Previous filing
21 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BUCHAN JANE Director C/O IMMIX BIOPHARMA, INC., 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES /s/ Ilya Rachman as Attorney-In-Fact for Jane Buchan 23 Jun 2025 0001342502

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IMMX Common Stock 22,455 20 Jun 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Stock Option (Right to Buy) Award $0 +33,000 $0.000000 33,000 20 Jun 2025 Common Stock 33,000 $2.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Remarks:

See Power of Attorney filed as Exhibit 24.1 to the Form 3 filed by the Reporting Person on December 15, 2021.